These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 26272370)
1. The human rhabdomyosarcoma cell line TE671--Towards an innovative production platform for glycosylated biopharmaceuticals. Rosenlöcher J; Weilandt C; Sandig G; Reinke SO; Blanchard V; Hinderlich S Protein Expr Purif; 2015 Nov; 115():83-94. PubMed ID: 26272370 [TBL] [Abstract][Full Text] [Related]
2. N-glycosylation and biological activity of recombinant human alpha1-antitrypsin expressed in a novel human neuronal cell line. Blanchard V; Liu X; Eigel S; Kaup M; Rieck S; Janciauskiene S; Sandig V; Marx U; Walden P; Tauber R; Berger M Biotechnol Bioeng; 2011 Sep; 108(9):2118-28. PubMed ID: 21495009 [TBL] [Abstract][Full Text] [Related]
3. N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line. Forno G; Bollati Fogolin M; Oggero M; Kratje R; Etcheverrigaray M; Conradt HS; Nimtz M Eur J Biochem; 2004 Mar; 271(5):907-19. PubMed ID: 15009203 [TBL] [Abstract][Full Text] [Related]
4. Characterization of N-linked glycosylation on recombinant glycoproteins produced in Pichia pastoris using ESI-MS and MALDI-TOF. Gong B; Cukan M; Fisher R; Li H; Stadheim TA; Gerngross T Methods Mol Biol; 2009; 534():213-23. PubMed ID: 19277549 [TBL] [Abstract][Full Text] [Related]
5. Development and analysis of alpha 1-antitrypsin neoglycoproteins: the impact of additional N-glycosylation sites on serum half-life. Lusch A; Kaup M; Marx U; Tauber R; Blanchard V; Berger M Mol Pharm; 2013 Jul; 10(7):2616-29. PubMed ID: 23668542 [TBL] [Abstract][Full Text] [Related]
6. Glycoproteins from insect cells: sialylated or not? Marchal I; Jarvis DL; Cacan R; Verbert A Biol Chem; 2001 Feb; 382(2):151-9. PubMed ID: 11308014 [TBL] [Abstract][Full Text] [Related]
7. Influence of lactation parameters on the N-glycosylation of recombinant human C1 inhibitor isolated from the milk of transgenic rabbits. Koles K; van Berkel PH; Mannesse ML; Zoetemelk R; Vliegenthart JF; Kamerling JP Glycobiology; 2004 Nov; 14(11):979-86. PubMed ID: 15253928 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of recombinant human EPO production and glycosylation in serum-free suspension culture of CHO cells through expression and supplementation of 30Kc19. Park JH; Wang Z; Jeong HJ; Park HH; Kim BG; Tan WS; Choi SS; Park TH Appl Microbiol Biotechnol; 2012 Nov; 96(3):671-83. PubMed ID: 22714097 [TBL] [Abstract][Full Text] [Related]
9. Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Shin YJ; Chong YJ; Yang MS; Kwon TH Plant Biotechnol J; 2011 Dec; 9(9):1109-19. PubMed ID: 21801300 [TBL] [Abstract][Full Text] [Related]
10. Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Ghaderi D; Zhang M; Hurtado-Ziola N; Varki A Biotechnol Genet Eng Rev; 2012; 28():147-75. PubMed ID: 22616486 [TBL] [Abstract][Full Text] [Related]
11. Expression and N-glycan analysis of human 90K glycoprotein in Drosophila S2 cells. Kim KR; Kim YK; Cheong H; Kim JY; Cha HJ Enzyme Microb Technol; 2013 Aug; 53(3):170-3. PubMed ID: 23830458 [TBL] [Abstract][Full Text] [Related]
12. Methods in enzymology: O-glycosylation of proteins. Peter-Katalinić J Methods Enzymol; 2005; 405():139-71. PubMed ID: 16413314 [TBL] [Abstract][Full Text] [Related]
13. The analysis of N-glycans of cell membrane proteins from human hematopoietic cell lines reveals distinctions in their pattern. Reinke SO; Bayer M; Berger M; Hinderlich S; Blanchard V Biol Chem; 2012 Aug; 393(8):731-47. PubMed ID: 22944676 [TBL] [Abstract][Full Text] [Related]
14. Preliminary investigation of glycosylated proteins by capillary electrophoresis and capillary electrophoresis/mass spectrometry using electrospray ionization and by matrix-assisted laser desorption ionization/time-to-flight mass spectrometry. Bonfichi R; Sottani C; Colombo L; Coutant JE; Riva E; Zanette D Rapid Commun Mass Spectrom; 1995; Spec No():S95-106. PubMed ID: 8829487 [TBL] [Abstract][Full Text] [Related]
15. Impact of host cell line choice on glycan profile. Goh JB; Ng SK Crit Rev Biotechnol; 2018 Sep; 38(6):851-867. PubMed ID: 29262720 [TBL] [Abstract][Full Text] [Related]
16. Appropriate mammalian expression systems for biopharmaceuticals. Werner RG; Noé W; Kopp K; Schlüter M Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718 [TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric quantification of neutral and sialylated N-glycans from a recombinant therapeutic glycoprotein produced in the two Chinese hamster ovary cell lines. Jang KS; Kim YG; Gil GC; Park SH; Kim BG Anal Biochem; 2009 Mar; 386(2):228-36. PubMed ID: 19135424 [TBL] [Abstract][Full Text] [Related]
18. The sweet tooth of biopharmaceuticals: importance of recombinant protein glycosylation analysis. Lingg N; Zhang P; Song Z; Bardor M Biotechnol J; 2012 Dec; 7(12):1462-72. PubMed ID: 22829536 [TBL] [Abstract][Full Text] [Related]
19. Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry. Morelle W; Faid V; Chirat F; Michalski JC Methods Mol Biol; 2009; 534():5-21. PubMed ID: 19277556 [TBL] [Abstract][Full Text] [Related]
20. Top-down sequencing of O-glycoproteins by in-source decay matrix-assisted laser desorption ionization mass spectrometry for glycosylation site analysis. Hanisch FG Anal Chem; 2011 Jun; 83(12):4829-37. PubMed ID: 21526855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]